Advertisement

Review Series - January 7, 2016

Introduced by Dr. Bob Lowenberg and Dr. Jacob Rowe, this review series offers comprehensive updates on the latest insights into the pathobiology of the disease as well as the current and emerging directions of treatment.

 

 

 

 

 

 

Emerging therapeutic drugs for AML
Eytan Stein and Martin Tallman

 


Blood Journal Review Series